Holen Sie sich die Stockscreener-App
9.11
1.41%
-0.13
Handel nachbörslich:
9.30
0.19
+2.09%
Schlusskurs vom Vortag:
$9.24
Offen:
$9.31
24-Stunden-Volumen:
116.49K
Relative Volume:
1.45
Marktkapitalisierung:
$253.38M
Einnahmen:
$21.25M
Nettoeinkommen (Verlust:
$-16.05M
KGV:
-14.93
EPS:
-0.61
Netto-Cashflow:
$-17.14M
1W Leistung:
+11.64%
1M Leistung:
+3.76%
6M Leistung:
+35.16%
1J Leistung:
+55.73%
1-Tages-Spanne:
$8.905
$9.42
1-Wochen-Bereich:
$7.93
$9.42
52-Wochen-Spanne:
$3.96
$9.42
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Firmenname
Fennec Pharmaceuticals Inc
Sektor
Branche
Telefon
(919) 636-4530
Adresse
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Vergleichen Sie FENC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
9.11 | 227.85M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-22 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | Eingeleitet | CapitalOne | Overweight |
| 2022-08-08 | Fortgesetzt | Craig Hallum | Buy |
| 2020-06-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-10-11 | Eingeleitet | Goldman | Buy |
Fennec Pharmaceuticals Inc Aktie (FENC) Neueste Nachrichten
Why Fennec Pharmaceuticals Inc. is moving todayPortfolio Profit Report & AI Enhanced Trading Alerts - Newser
Applying chart zones and confluence areas to Fennec Pharmaceuticals Inc.Weekly Gains Summary & Community Verified Swing Trade Signals - Newser
Can trapped investors hope for a rebound in Fennec Pharmaceuticals Inc.Weekly Stock Report & Community Consensus Stock Picks - Newser
How to interpret RSI for Fennec Pharmaceuticals Inc. stockWeekly Stock Recap & Weekly Setup with ROI Potential - Newser
Will Fennec Pharmaceuticals Inc. stock go up soon2025 Buyback Activity & Expert Approved Trade Ideas - Newser
Why Fennec Pharmaceuticals Inc. stock attracts strong analyst attention [2025 Historical Comparison]Community Trade Idea Sharing - Newser
How to manage a losing position in Fennec Pharmaceuticals Inc.Free Entry Points For Growing Stocks - Newser
Fennec Pharmaceuticals Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Measuring Fennec Pharmaceuticals Inc.’s beta against major indicesCapital Secure Pattern Signal Analysis Sheet - Newser
Stocks In Play: Fennec Pharmaceuticals Inc. - Barchart.com
Fennec Pharmaceuticals to Announce Q2 2025 Financial Results - TipRanks
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025 - The Manila Times
Fennec Pharmaceuticals to announce Q2 2025 financial results on Aug. 14. - AInvest
Fennec Pharmaceuticals Inc. stock outlook for YEAREarly Entry Ideas with Momentum Potential - Newser
Real time pattern detection on Fennec Pharmaceuticals Inc. stockDividend Strategy Summary With 10-Year Outlook - Newser
Adherex Technologies (FENC) to Release Earnings on Tuesday - Defense World
What makes Fennec Pharmaceuticals Inc. stock price move sharplyShort-Term Swing Opportunity Summary Sheet - Newser
Fennec Pharmaceuticals FENC Q2 2025 Earnings Preview Downside Concerns Amid Product Vulnerability Issues - AInvest
How Fennec Pharmaceuticals Inc. stock performs during market volatilityLong-Term Signal Tracking and Profit Summary - Newser
Full technical analysis of Fennec Pharmaceuticals Inc. stockPredictive Model for Intraday Swing Forecast - Newser
Anterix Holds Virtual Annual Stockholders Meeting - The Globe and Mail
Paymentus Holdings: Strong Growth and Raised Guidance - The Globe and Mail
Using data filters to optimize entry into Fennec Pharmaceuticals Inc.Rapid Trade Forecast Based on Indicators - Newser
Evaluating Fennec Pharmaceuticals Inc. with trendline analysisCapital Protection Strategy With Risk Analysis - Newser
Adherex Technologies (NASDAQ:FENC) Trading Up 6.1% – Still a Buy? - Defense World
Is it too late to sell Fennec Pharmaceuticals Inc.Summary of Long-Term Buy Zone Stocks - Newser
Using economic indicators to assess Fennec Pharmaceuticals Inc. potentialFree Early Entry Tips With Low Risk Zone - Newser
What is the dividend policy of Fennec Pharmaceuticals Inc. stockCapitalize on market momentum for maximum gains - Jammu Links News
What institutional investors are buying Fennec Pharmaceuticals Inc. stockSuperior portfolio returns - Jammu Links News
How does Fennec Pharmaceuticals Inc. compare to its industry peersExceptional profit potential - Jammu Links News
Is Fennec Pharmaceuticals Inc. a good long term investmentDiscover undervalued opportunities early - Jammu Links News
Is it the right time to buy Fennec Pharmaceuticals Inc. stockDiscover undervalued stocks ready to soar - Jammu Links News
What are the technical indicators suggesting about Fennec Pharmaceuticals Inc.Tremendous growth opportunities - Jammu Links News
Finanzdaten der Fennec Pharmaceuticals Inc-Aktie (FENC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):